Skeletal muscle and childhood cancer: Where are we now and where we go from here
Open Access
- 20 May 2021
- journal article
- review article
- Published by Wiley in Aging and Cancer
- Vol. 2 (1-2), 13-35
- https://doi.org/10.1002/aac2.12027
Abstract
Skeletal muscle (muscle) is essential for physical health and for metabolic integrity, with sarcopenia (progressive muscle mass loss and weakness), a pre-curser of aging and chronic disease. Loss of lean mass and muscle quality (force generation per unit of muscle) in the general population are associated with fatigue, weakness, and slowed walking speed, eventually interfering with the ability to maintain physical independence, and impacting participation in social roles and quality of life. Muscle mass and strength impairments are also documented during childhood cancer treatment, which often persist into adult survivorship, and contribute to an aging phenotype in this vulnerable population. Although several treatment exposures appear to confer increased risk for loss of mass and strength that persists after therapy, the pathophysiology responsible for poor muscle quantity and quality is not well understood in the childhood cancer survivor population. This is partly due to limited access to both pediatric and adult survivor muscle tissue samples, and to difficulties surrounding non-invasive investigative approaches for muscle assessment. Because muscle accounts for just under half of the body's mass, and is essential for movement, metabolism and metabolic health, understanding mechanisms of injury responsible for both initial and persistent dysfunction is important, and will provide a foundation for intervention. The purpose of this review is to provide an overview of the available evidence describing associations between childhood cancer, its treatment, and muscle outcomes, identifying gaps in current knowledge.Keywords
This publication has 166 references indexed in Scilit:
- Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood CancerJAMA, 2013
- Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignanciesPediatric Blood & Cancer, 2011
- Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemiaCancer, 2011
- Physical activity among adult survivors of childhood lower-extremity sarcomaJournal of Cancer Survivorship, 2011
- Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on SarcopeniaJournal of the American Medical Directors Association, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Prospective medical assessment of adults surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort StudyPediatric Blood & Cancer, 2010
- Remodeling of the neuromuscular junction precedes sarcopenia related alterations in myofibersExperimental Gerontology, 2010
- Mitochondria—A Nexus for Aging, Calorie Restriction, and Sirtuins?Cell, 2008
- Reactive oxygen species have a causal role in multiple forms of insulin resistanceNature, 2006